Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FH5FN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,357
Award facts
- Contract value 100% obligated
- $11,357.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,357.40 by the Defense Logistics Agency (DLA) on September 25, 2025. The contract covers the supply of NUCALA 100 MG/ML Auto-Injector, a specialty pharmaceutical product, with an ultimate completion date of September 26, 2025. This delivery order operates under a firm fixed-price arrangement with no set-aside designation and reflects the company's ongoing role as a critical supplier within the federal pharmaceutical distribution network.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The parent IDC enables the DLA to issue delivery orders for a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities worldwide, encompassing prescription medications, biologics, over-the-counter drugs, and specialty items such as auto-injectors and oncology treatments. This delivery order for NUCALA, a biologic respiratory medication, exemplifies the company's established position as a key pharmaceutical supplier for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FH5FN?
SPE2DB25FH5FN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FH5FN worth?
The government has obligated $11,357 on SPE2DB25FH5FN.
Is contract SPE2DB25FH5FN an order under another contract?
Yes. SPE2DB25FH5FN is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5FN competed?
The extent of competition for SPE2DB25FH5FN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award